Ceterix Orthopaedics

Ceterix Orthopaedics is a medical device company that developed the NovoStitch Pro Meniscal Repair System, a specialized tool for arthroscopic knee surgery. The company's technology allows surgeons to place sutures in tight joint compartments, enabling the repair of complex meniscal tears—such as horizontal, radial, and root tears—that were previously difficult to treat. By facilitating meniscal repair rather than removal (meniscectomy), Ceterix's products help preserve joint health and reduce the long-term risk of osteoarthritis. The system features an ergonomic handle and a unique suture-passing mechanism designed to improve surgical workflow and precision. Founded in 2010 and based in Fremont, California, the company was acquired by Smith & Nephew in 2019 for up to $105 million to expand its sports medicine portfolio.